Simon Fraser University, Burnaby, BC, Canada.
University of Saskatchewan, Saskatoon, SK, Canada.
Int J Health Policy Manag. 2020 Jan 1;9(1):1-5. doi: 10.15171/ijhpm.2019.82.
One of the glaring gaps in Canada's universal healthcare system is the low level of public financing of prescription drugs - 42.7% of total spending in 2018. At the federal level there is renewed interest in moving towards universal coverage, supported by a recently commissioned report on how to achieve it. It will take superb political navigation to extract Canadian pharmaceutical policy and practice from the grasp of interests that profit handsomely from the status quo. This perspective suggests the conditions under which a genuinely fair, effective, and efficient pharmacare plan can emerge.
加拿大全民医保体系的一个明显缺陷是处方药公共资金投入水平低——2018 年占总支出的 42.7%。在联邦一级,人们对实现全民医保的兴趣重新燃起,最近发布的一份关于如何实现这一目标的报告也提供了支持。要想让加拿大的医药政策和实践摆脱那些从现状中获利丰厚的利益集团的控制,高超的政治驾驭能力不可或缺。本文从这一角度探讨了真正公平、有效和高效的药品福利计划出现的条件。